Trial Profile
A Test-retest Study to Assess Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of AH111585 (18F) Injection.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Aug 2016
Price :
$35
*
At a glance
- Drugs Fluciclatide F-18 (Primary)
- Indications Solid tumours
- Focus Diagnostic use
- Sponsors GE Healthcare
- 30 Apr 2014 New trial record